Your browser doesn't support javascript.
loading
Radioimmunotherapy with 131 I-rituximab for patients with relapsed or refractory follicular or mantle cell lymphoma.
Jang, Yoon Jung; Lim, Sang Moo; Lee, Inki; Byun, Byung Hyun; Lim, Ilhan; Kim, Byung Il; Choi, Chang Woon; Lee, Seung-Sook; Suh, Cheolwon; Yoon, Dok Hyun; Kim, Inho; Nam, Seung-Hyun; Lee, Mark Hong; Won, Jong Ho; Kong, Jee Hyun; Jeong, Seong Hyun; Oh, Suk Joong; Park, Keon Woo; Han, Jae Joon; Song, Moo-Kon; Yang, Sung Hyun; Na, Im Il; Lee, Hyo-Rak; Shin, Dong-Yeop; Kang, Hye Jin.
  • Jang YJ; Department of Hematology and Oncology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.
  • Lim SM; Department of Nuclear Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.
  • Lee I; Department of Nuclear Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.
  • Byun BH; Department of Nuclear Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.
  • Lim I; Department of Nuclear Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.
  • Kim BI; Department of Nuclear Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.
  • Choi CW; Department of Nuclear Medicine, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.
  • Lee SS; Department of Pathology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.
  • Suh C; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Yoon DH; Department of Oncology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Kim I; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
  • Nam SH; Division of Hematology-Oncology, Department of Internal Medicine, Kyung Hee University at Gangdong, Seoul, Republic of Korea.
  • Lee MH; Department of Internal Medicine, Konkuk University Medical Center, Seoul, Republic of Korea.
  • Won JH; Department of Internal Medicine, Soonchunhyang University Seoul Hospital, Seoul, Republic of Korea.
  • Kong JH; Division of Oncology and Hematology, Department of Internal Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Republic of Korea.
  • Jeong SH; Department of Hematology-Oncology, Ajou University School of Medicine, Suwon, Republic of Korea.
  • Oh SJ; Department of Internal Medicine, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
  • Park KW; Department of Internal Medicine, Dankook University, College of Medicine, Cheonan, Republic of Korea.
  • Han JJ; Division of Medical Oncology-Hematology, Department of Internal Medicine, Kyung Hee University Hospital, Kyung Hee University College of Medicine, Seoul, Republic of Korea.
  • Song MK; Division of Hematology-Oncology, Department of Medicine, Hanyang University Changwon Hanmaeum Hospital, Changwon, Republic of Korea.
  • Yang SH; Department of Hematology and Oncology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.
  • Na II; Department of Hematology and Oncology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.
  • Lee HR; Department of Hematology and Oncology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.
  • Shin DY; Department of Hematology and Oncology, Korea Cancer Center Hospital, Korea Institute of Radiological and Medical Sciences, Seoul, Republic of Korea.
  • Kang HJ; Division of Hematology and Medical Oncology, Department of Internal Medicine, Seoul National University Hospital, Seoul, Republic of Korea.
Asia Pac J Clin Oncol ; 19(6): 690-696, 2023 Dec.
Article en En | MEDLINE | ID: mdl-36915956
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma Folicular / Linfoma de Células del Manto Límite: Adult / Humans Idioma: En Año: 2023 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Linfoma Folicular / Linfoma de Células del Manto Límite: Adult / Humans Idioma: En Año: 2023 Tipo del documento: Article